Last updated on April 17, 2014 at 13:40 EDT

Patheon Announces Annual and Special Shareholder Meeting Webcast

March 14, 2013

TORONTO, March 14, 2013 /PRNewswire/ – Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial
manufacturing services to the global pharmaceutical industry, announced
today that it will host a conference call and webcast allowing
interested persons to listen to its Annual and Special Meeting of
Shareholders (the “Annual Meeting”) to be held on Thursday, March 28,
2013, beginning at 10:30 a.m. (EDT).  The Annual Meeting will be held
at The Hilton Hotel in Toronto, Ontario, Canada.  Patheon’s 2012 Annual
Report and its Proxy Statement and Information Circular for the Annual
Meeting can be viewed at www.envisionreports.com/Patheon2013.

Interested parties are invited to access the conference call, via
telephone, in listen-only mode, toll free at 1-888-231-8191 (U.S.,
including Puerto Rico) and 1-647-427-7450 (Canada and International). 
Listeners are encouraged to dial in five to fifteen minutes in advance
to avoid delays.  The webcast and accompanying slides will also be
available for viewing during the Annual Meeting by accessing http://ir.patheon.com/events.cfm.

A replay of the conference call will be available between Thursday,
March 28, 2013 and Thursday, April 4, 2013 by dialing 1-855-859-2056
(toll free) or 1-403-451-9481, and entering identification number
99158691#. The webcast and accompanying slides will be archived at http://ir.patheon.com/events.cfm.

About Patheon Inc.

Patheon Inc. (TSX: PTI) is a leading provider of contract development
and commercial manufacturing services to the global pharmaceutical
industry for a full array of solid and sterile dosage forms.  Through
the company’s recent acquisition of Banner Pharmacaps – a market leader
in soft gelatin capsule technology – Patheon now also includes a
proprietary products and technology business.

Patheon provides the highest quality products and services to
approximately 300 of the world’s leading pharmaceutical and
biotechnology companies.  The company’s integrated network consists of
18 locations, including 14 commercial contract manufacturing facilities
and 12 development centers across North America and Europe.  Patheon
enables customer products to be launched with confidence anywhere in
the world.  For more information visit www.patheon.com.

SOURCE Patheon Inc.

Source: PR Newswire